234 related articles for article (PubMed ID: 23349500)
1. β-Cell-specific protein kinase A activation enhances the efficiency of glucose control by increasing acute-phase insulin secretion.
Kaihara KA; Dickson LM; Jacobson DA; Tamarina N; Roe MW; Philipson LH; Wicksteed B
Diabetes; 2013 May; 62(5):1527-36. PubMed ID: 23349500
[TBL] [Abstract][Full Text] [Related]
2. Cooperation between cAMP signalling and sulfonylurea in insulin secretion.
Shibasaki T; Takahashi T; Takahashi H; Seino S
Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():118-25. PubMed ID: 25200305
[TBL] [Abstract][Full Text] [Related]
3. Glucotoxicity inhibits cAMP-protein kinase A-potentiated glucose-stimulated insulin secretion in pancreatic β-cells.
Kong X; Yan D; Wu X; Guan Y; Ma X
J Diabetes; 2015 May; 7(3):378-85. PubMed ID: 24981285
[TBL] [Abstract][Full Text] [Related]
4. Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells.
Zhu ZQ; Wang D; Xiang D; Yuan YX; Wang Y
Metabolism; 2014 Jan; 63(1):120-6. PubMed ID: 24140090
[TBL] [Abstract][Full Text] [Related]
5. Synaptotagmin-7 phosphorylation mediates GLP-1-dependent potentiation of insulin secretion from β-cells.
Wu B; Wei S; Petersen N; Ali Y; Wang X; Bacaj T; Rorsman P; Hong W; Südhof TC; Han W
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9996-10001. PubMed ID: 26216970
[TBL] [Abstract][Full Text] [Related]
6. Involvement of cAMP/EPAC/TRPM2 activation in glucose- and incretin-induced insulin secretion.
Yosida M; Dezaki K; Uchida K; Kodera S; Lam NV; Ito K; Rita RS; Yamada H; Shimomura K; Ishikawa SE; Sugawara H; Kawakami M; Tominaga M; Yada T; Kakei M
Diabetes; 2014 Oct; 63(10):3394-403. PubMed ID: 24824430
[TBL] [Abstract][Full Text] [Related]
7. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
Irwin N; Hunter K; Montgomery IA; Flatt PR
Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin attenuates cAMP-PKA signaling to evoke insulinostatic cascade in islet β-cells.
Dezaki K; Damdindorj B; Sone H; Dyachok O; Tengholm A; Gylfe E; Kurashina T; Yoshida M; Kakei M; Yada T
Diabetes; 2011 Sep; 60(9):2315-24. PubMed ID: 21788571
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways.
MacDonald PE; Wang X; Xia F; El-kholy W; Targonsky ED; Tsushima RG; Wheeler MB
J Biol Chem; 2003 Dec; 278(52):52446-53. PubMed ID: 14565957
[TBL] [Abstract][Full Text] [Related]
10. Xanthine-derived KMUP-1 reverses glucotoxicity-activated Kv channels through the cAMP/PKA signaling pathway in rat pancreatic β cells.
Lee CH; Chu CS; Tsai HJ; Ke LY; Lee HC; Yeh JL; Chen CH; Wu BN
Chem Biol Interact; 2018 Jan; 279():171-176. PubMed ID: 29183753
[TBL] [Abstract][Full Text] [Related]
11. cAMP-mediated signaling normalizes glucose-stimulated insulin secretion in uncoupling protein-2 overexpressing beta-cells.
McQuaid TS; Saleh MC; Joseph JW; Gyulkhandanyan A; Manning-Fox JE; MacLellan JD; Wheeler MB; Chan CB
J Endocrinol; 2006 Sep; 190(3):669-80. PubMed ID: 17003268
[TBL] [Abstract][Full Text] [Related]
12. Protein acetylation derepresses Serotonin Synthesis to potentiate Pancreatic Beta-Cell Function through HDAC1-PKA-Tph1 signaling.
Zhang Y; Wang S; Zhang L; Zhou F; Zhu K; Zhu Q; Liu Q; Liu Y; Jiang L; Ning G; Bi Y; Zhou L; Wang X
Theranostics; 2020; 10(16):7351-7368. PubMed ID: 32641996
[No Abstract] [Full Text] [Related]
13. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
Winzell MS; Ahrén B
J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 alleviates angiotensin II-induced senescence in vascular smooth muscle cells by inhibiting Rac1 activation via a cAMP/PKA-dependent pathway.
Zhao L; Li AQ; Zhou TF; Zhang MQ; Qin XM
Am J Physiol Cell Physiol; 2014 Dec; 307(12):C1130-41. PubMed ID: 25298426
[TBL] [Abstract][Full Text] [Related]
15. Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion.
Gheni G; Ogura M; Iwasaki M; Yokoi N; Minami K; Nakayama Y; Harada K; Hastoy B; Wu X; Takahashi H; Kimura K; Matsubara T; Hoshikawa R; Hatano N; Sugawara K; Shibasaki T; Inagaki N; Bamba T; Mizoguchi A; Fukusaki E; Rorsman P; Seino S
Cell Rep; 2014 Oct; 9(2):661-73. PubMed ID: 25373904
[TBL] [Abstract][Full Text] [Related]
16. Achieving "PeaK-A" insulin secretion.
Evans-Molina C; Mirmira RG
Diabetes; 2013 May; 62(5):1389-90. PubMed ID: 23613561
[No Abstract] [Full Text] [Related]
17. Exendin-4 stimulation of cyclin A2 in beta-cell proliferation.
Song WJ; Schreiber WE; Zhong E; Liu FF; Kornfeld BD; Wondisford FE; Hussain MA
Diabetes; 2008 Sep; 57(9):2371-81. PubMed ID: 18544709
[TBL] [Abstract][Full Text] [Related]
18. NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion.
Li N; Li B; Brun T; Deffert-Delbouille C; Mahiout Z; Daali Y; Ma XJ; Krause KH; Maechler P
Diabetes; 2012 Nov; 61(11):2842-50. PubMed ID: 22933115
[TBL] [Abstract][Full Text] [Related]
19. Liraglutide regulates the viability of pancreatic α-cells and pancreatic β-cells through cAMP-PKA signal pathway.
Xu X; Chen J; Hu L; Liang M; Wang X; Feng S; Shen J; Luan X
Life Sci; 2018 Feb; 195():87-94. PubMed ID: 29225111
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4 overcomes cytokine-induced decreases in gap junction coupling via protein kinase A and Epac2 in mouse and human islets.
Farnsworth NL; Walter R; Piscopio RA; Schleicher WE; Benninger RKP
J Physiol; 2019 Jan; 597(2):431-447. PubMed ID: 30412665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
